NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 80 filers reported holding NEXTCURE INC in Q2 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,838,000 | -19.8% | 228,855 | 0.0% | 0.01% | -17.6% |
| Q1 2021 | $2,291,000 | -70.7% | 228,855 | -68.1% | 0.02% | -72.1% |
| Q4 2020 | $7,819,000 | +22.9% | 717,357 | -0.8% | 0.06% | 0.0% |
| Q3 2020 | $6,364,000 | -59.4% | 723,191 | -1.1% | 0.06% | -62.3% |
| Q2 2020 | $15,673,000 | -42.2% | 731,016 | -0.1% | 0.16% | -54.5% |
| Q1 2020 | $27,139,000 | -36.7% | 732,091 | -3.9% | 0.36% | -6.6% |
| Q4 2019 | $42,894,000 | +2679.9% | 761,476 | +1423.0% | 0.38% | +2440.0% |
| Q3 2019 | $1,543,000 | +106.0% | 50,000 | 0.0% | 0.02% | +114.3% |
| Q2 2019 | $749,000 | – | 50,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |